🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

1,328 results for “Xiyuan Hospital of China Academy of Chinese Medical Sciences” Clear

  1. Test preparation：Methylcholine chloroacetate for inhalation

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Asthma

    approved small molecule completed

    1 trial

  2. Test preparation：Methylcholine chloroacetate for inhalation

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Healthy People

    approved small molecule completed

    1 trial

  3. Thymosin Alpha 1

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Pancreatitis, Acute Necrotizing

    approved small molecule completed

    1 trial

  4. Ticagrelor

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Coronary Heart Disease

    approved small molecule active

    1 trial

  5. Ticagrelor

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Coronary Artery Disease

    approved small molecule completed

    1 trial

  6. Tirofiban hydrochloride sodium chloride injection

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Branch Atheromatous Disease

    approved small molecule completed

    1 trial

  7. Tofacitinib and Acitretin Capsules.

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Primary Cutaneous Amyloidosis

    approved small molecule active

    1 trial

  8. Treatment group

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hypertension

    approved small molecule completed

    1 trial

  9. Trimetazidine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Coronary Heart Disease

    approved small molecule active

    1 trial

  10. Triple combination therapy group

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Type 2 Diabetes Mellitus

    approved small molecule completed

    1 trial

  11. Triptergium Wilfordii

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Psoriasis Vulgaris

    approved small molecule active

    1 trial

  12. Ursodeoxycholic acid combined with total glucosides of paeony

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hepatitis

    approved small molecule active

    1 trial

  13. Vardenafil

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Erectile Dysfunction

    approved small molecule active

    1 trial

  14. Wangbi granules

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Rheumatoid Arthritis

    approved small molecule active

    1 trial

  15. Warfarin

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Anticoagulation

    approved small molecule active

    1 trial

  16. Wen Xin granule

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Coronary Heart Disease

    approved small molecule active

    1 trial

  17. Xiang Sha Liu Jun Zi Decoction dry powder

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hepatocellular Carcinoma

    approved small molecule completed

    1 trial

  18. Xingnaojing injection

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Acute Ischemic Stroke

    approved small molecule active

    1 trial

  19. Xuebijing Injection

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Sepsis

    approved small molecule completed

    2 trials

  20. Xuesaitong Soft Capsule

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Coronary Heart Disease

    approved small molecule active

    2 trials

  21. Xueshuanxinmaining tablet

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Coronary Heart Disease

    approved small molecule active

    1 trial

  22. Zhenyuan capsule

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Stable Coronary Heart Disease

    approved small molecule active

    1 trial

  23. Zushima plaster with high dose

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Osteoarthritis

    approved small molecule completed

    1 trial

  24. albumin

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Sepsis

    approved small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources